Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Endocrine
Erschienen in: Endocrine 3/2019

19.07.2019 | Original Article

Adrenalectomy impairs vasoactive intestinal peptide-induced changes in food intake and plasma parameters

verfasst von: Marcela Cristina Garnica-Siqueira, Andressa Bussetti Martins, Larissa Rugila dos Stopa, Camila Franciele de Souza, Dimas Augusto Morozin Zaia, Cristiane Mota Leite, Cássia Thaïs Bussamra Vieira Zaia, Ernane Torres Uchôa

Erschienen in: Endocrine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study is to evaluate the effects of adrenalectomy (ADX) and glucocorticoid in the changes induced by intracerebroventricular (ICV) administration of vasoactive intestinal peptide (VIP) on food intake and plasma parameters, as well as VIP receptor subtype 2 (VPAC2) mRNA expression in different hypothalamic nuclei of male rats.

Methods

Male Wistar rats (260–280 g) were subjected to ADX or sham surgery, 7 days before the experiments. Half of ADX animals received corticosterone (ADX + CORT) in the drinking water. Animals with 16 h of fasting received ICV microinjection of VIP or saline (0.9% NaCl). After 15 min: (1) animals were fed, and the amount of food ingested was quantified for 120 min; or (2) animals were euthanized and blood was collected for biochemical measurements. Determination of VPAC2 mRNA levels in LHA, ARC, and PVN was performed from animals with microinjection of saline.

Results

VIP treatment promoted the anorexigenic effect, which was not observed in ADX animals. Microinjection of VIP also induced an increase in blood plasma glucose and corticosterone levels, and a reduction in free fatty acid plasma levels, but adrenalectomy abolished these effects. In addition, adrenalectomy reduced mRNA expression of VPAC2 in the lateral hypothalamic area and arcuate nucleus, but not in the paraventricular nucleus.

Conclusions

These results suggest that adrenal glands are required for VIP-induced changes in food intake and plasma parameters, and these responses are associated with reduction in the expression of VPAC2 in the hypothalamus after adrenalectomy.
Literatur
1.
A.J. Harmar, J. Fahrenkrug, I. Gozes, M. Laburthe, V. May, J.R. Pisegna, D. Vaudry, H. Vaudry, J.A. Waschek, S.I. Said, Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1. Br. J. Pharmacol. 166, 4–17 (2012)CrossRefPubMedPubMedCentral
2.
E.M. Lutz, S. Mendelson, K. West, R. Mitchell, A.J. Harmar, Molecular characterisation of novel receptors for PACAP and VIP. Biochem. Soc. Trans. 23, 83S (1995)CrossRefPubMed
3.
K.M. Joo, Y.H. Chung, M.K. Kim, R.H. Nam, B.L. Lee, K.H. Lee, C.I. Cha, Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J. Comp. Neurol. 476, 388–413 (2004)CrossRefPubMed
4.
W.J. Sheward, E.M. Lutz, A.J. Harmar, The distribution of vasoactive intestinal peptide2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization. Neuroscience 67, 409–418 (1995)CrossRefPubMed
5.
L.M. Gerhold, T.L. Horvath, M.E. Freeman, Vasoactive intestinal peptide fibers innervate neuroendocrine dopaminergic neurons. Brain Res. 919, 48–56 (2001)CrossRefPubMed
6.
D. Vaudry, B.J. Gonzalez, M. Basille, L. Yon, A. Fournier, H. Vaudry, Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52, 269–324 (2000)PubMed
7.
T.B. Usdin, T.I. Bonner, E. Mezey, Two receptors for vasoactive intestinal polypeptide with similar and complementary distributions. Endocrinology 135, 2662–2680 (1994)CrossRefPubMed
8.
S. Ghourab, K.E. Beale, N.M. Semjonous, K.A. Simpson, N.M. Martin, M.A. Ghatei, S.R. Bloom, K.L. Smith, Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake. Regul. Pept. 172, 8–15 (2011)CrossRefPubMed
9.
A.B. Martins, M.C. Garnica-Siqueira, D.A.M. Zaia, C.T.B.V. Zaia, E.T. Uchôa, Oxytocin participates on the effects of vasoactive intestinal peptide on food intake and plasma parameters. Mol. Cell. Biochem. 437, 177–183 (2018)CrossRefPubMed
10.
L.D. Alexander, L.D. Sander, Vasoactive intestinal peptide stimulates ACTH and corticosterone release after injection into the PVN. Regul. Pept. 51, 221–227 (1994)CrossRefPubMed
11.
J. Wang, A. Akabayashi, J. Dourmashkin, H.J. Yu, J.T. Alexander, H.J. Chae, S.F. Leibowitz, Neuropeptide Y in relation to carbohydrate intake, corticosterone and dietary obesity. Brain Res. 802, 75–88 (1998)CrossRefPubMed
12.
B.A. Kumar, S.F. Leibowitz, Impact of acute corticosterone administration on feeding and macronutrient self-selection patterns. Am. J. Physiol. 254, R222–R228 (1988)PubMed
13.
A.M. Strack, R.J. Sebastian, M.W. Schwartz, M.F. Dallman, Glucocorticoids and insulin: reciprocal signals for energy balance. Am. J. Physiol. 268, R142–R149 (1995)PubMed
14.
E.T. Uchoa, H.A.C. Sabino, S.G. Ruginsk, J. Antunes-Rodrigues, L.L.K. Elias, Hypophagia induced by glucocorticoid deficiency is associated with an increased activation of satiety-related responses. J. Appl. Physiol. 106, 596–604 (2009)CrossRefPubMed
15.
A. Akabayashi, C.T.B.V. Zaia, S.M. Gabriel, I. Silva, W.K. Cheung, S.F. Leibowitz, Intracerebroventricular Injection of dibutyryl cyclic adenosine-3’,5’-monophosphate increases hypothalamic levels of neuropeptide Y. Brain Res. 660, 323–328 (1994)CrossRefPubMed
16.
M.F. Dallman, S.F. Akana, L. Jacobson, N. Levin, C.S. Cascio, J. Shinsako, Characterization of corticosterone feedback regulation of ACTH secretion. Ann. N. Y. Acad. Sci. 512, 402–414 (1987)CrossRefPubMed
17.
M. Aronsson, K. Fuxe, Y. Dong, L.F. Agnati, S. Okret, J.A. Gustafsson, Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc. Natl Acad. Sci. USA 85, 9331–9335 (1988)CrossRefPubMedPubMedCentral
18.
S. Ceccatelli, M. Eriksson, T. Hökfelt, Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 49, 309–323 (1989)CrossRefPubMed
19.
P.M. Jones, D.J. O’Halloran, M.A. Ghatei, J. Domin, S.R. Bloom, The influence of adrenal hormone status on neuroendocrine peptides in the rat anterior pituitary gland. J. Endocrinol. 127, 437–444 (1990)CrossRefPubMed
20.
K.S.L. Lam, G. Srivastava, S.P. Tam, Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary. Neuroendocrinology 56, 32–37 (1992)CrossRefPubMed
21.
R. Guillemin, G.W. Clayton, H.S. Lipscomb, J.D. Smith, Fluorometric measurement of rat plasma and adrenal corticosterone concentration. A note on technical details. J. Lab. Clin. Med. 53, 830–832 (1959)PubMed
22.
G. Paxinos, C. Watson., The Rat Brain in Stereotaxic Coordinates. (Academic Press, San Diego, 2009)
23.
K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real- time quantitative PCR and the 2−ΔΔCt method. Methods 25, 402–408 (2001)CrossRefPubMed
24.
T. Tachibana, S. Tomonaga, D. Oikawa, S. Saito, T. Takagi, E.S. Saito, T. Boswell, M. Furuse, Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide inhibit feeding in the chick brain by different mechanisms. Neurosci. Lett. 348, 25–28 (2003)CrossRefPubMed
25.
P. Trinder, Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22, 158–161 (1969)CrossRefPubMedPubMedCentral
26.
K. Falholt, B. Lund, W. Falholt, An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin. Chim. Acta 46, 105–111 (1973)CrossRefPubMed
27.
E.T. Uchoa, L.E.C.M. da Silva, M. de Castro, J. Antunes-Rodrigues, L.L.K. Elias, Corticotrophin-releasing factor mediates hypophagia after adrenalectomy, increasing meal-related satiety responses. Horm. Behav. 58, 714–719 (2010)CrossRefPubMed
28.
S.I. Khan, M.A. Cline, T. Aramaki, H. Ueda, T. Tachibana, Feeding response following central administration of chicken vasoactive intestinal peptide in chicks. Gen. Comp. Endocrinol. 184, 61–66 (2013)CrossRefPubMed
29.
M.C. Garnica-Siqueira, A.B. Martins, D.A.M. Zaia, C.M. Leite, E.T. Uchôa, C.T.B.V. Zaia, Corticotrophin-releasing factor mediates vasoactive intestinal peptide-induced hypophagia and changes in plasma parameters. Horm. Behav. 105, 138–145 (2018)CrossRefPubMed
30.
S.S. Almeida, L.H. Duntas, L. Dye, M.L. Nunes, C. Prasad, J.B.T. Rocha, P. Wainwright, C.T.B.V. Zaia, R.C.A. Guedes, Nutrition and brain function: a multidisciplinary virtual symposium. Nutr. Neurosci. 5, 311–320 (2002)CrossRefPubMed
31.
K. Matsuda, K. Maruyama, T. Nakamachi, T. Miura, M. Uchiyama, S. Shioda, Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus. Peptides 26, 1611–1616 (2005)CrossRefPubMed
32.
H.S. Beyer, S.G. Matta, B.M. Sharp, Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. Endocrinology 123, 2117–2123 (1988)CrossRefPubMed
33.
E.T. Uchoa, L.E.C.M. Silva, M. de Castro, J. Antunes-Rodrigues, L.L.K. Elias, Hypothalamic oxytocin neurons modulate hypophagic effect induced by adrenalectomy. Horm. Behav. 56, 532–538 (2009)CrossRefPubMed
34.
E.T. Uchoa, L.E.C.M. Silva, M. de Castro, J. Antunes-Rodrigues, L.L.K. Elias, Glucocorticoids are required for meal-induced changes in the expression of hypothalamic neuropeptides. Neuropeptides 46, 119–124 (2012)CrossRefPubMed
35.
L.D. Alexander, L.D. Sander, Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone. Neuropeptides 28, 167–173 (1995)CrossRefPubMed
36.
E. Savontaus, I.M. Conwell, S.L. Wardlaw, Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res. 958, 130–138 (2002)CrossRefPubMed
37.
N. Nagai, H. Kajikawa, T. Sasaki, K. Nagai, H. Nakagawa, Hyperglycemic response to intracranial injection of vasoactive intestinal peptide. J. Clin. Biochem. Nutr. 17, 29–34 (1994)CrossRef
38.
39.
A. Kawai, N. Kuzuya, On the role of glucocorticoid in glucose-induced insulin secretion. Horm. Metab. Res. 9, 361–365 (1977)CrossRefPubMed
40.
M. Kadekaro, M. Ito, P.M. Gross, Local cerebral glucose utilization is increased in acutely adrenaletomized rats. Neuroendocrinology 47, 329–334 (1988)CrossRefPubMed
41.
N. Paquot, P. Schneiter, E. Jéquier, L. Tappy, Effects of glucocorticoids and sympathomimetic agents on basal and insulin-stimulated glucose metabolism. Clin. Physiol. 15, 231–240 (1995)CrossRefPubMed
42.
R.J. Ho, H.C. Meng, The extracortical action of adrenocorticotrophic hormone on the elevation of plasma free fatty acids. Metabolism 13, 361–364 (1964)CrossRefPubMed
43.
M.T. Kibenge, C.B. Chan, Interactions between effects of adrenalectomy and diet on insulin secretion in fa/fa Zucker rats. Can. J. Physiol. Pharmacol. 79, 1–7 (2001)CrossRefPubMed
44.
M.R. Freedman, T.W. Castonguay, J.S. Stern, Effect of adrenalectomy and corticosterone replacement on meal patterns of Zucker rats. Am. J. Physiol. 249, R584–R594 (1985)PubMed
45.
46.
A.M. Ebeid, R.R. Attia, P. Sundaram, J.E. Fischer, Release of vasoactive intestinal peptide in the central nervous system in man. Am. J. Surg. 137, 123–127 (1979)CrossRefPubMed
47.
J. Miskowiak, B. Andersen, F. Stadil, J. Fahrenkrug, Meal stimulated levels of pancreatic polypeptide (PP) and vasoactive intestinal polypeptide (VIP) in gastroplasty for morbid obesity. Regul. Pept. 12, 231–236 (1985)CrossRefPubMed
48.
J.M. Kellum, J.F. Kuemmerle, T.M. O’Dorisio, P. Rayford, D. Martin, K. Engle, L. Wolf, H.J. Sugerman, Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann. Surg. 211, 763–770 (1990)CrossRefPubMedPubMedCentral
49.
R.F. Harty, P.H. Pearson, T.E. Solomon, J.E. McGuigan, Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regul. Pept. 36, 141–150 (1991)CrossRefPubMed
50.
I. Dawidson, M. Blom, T. Lundeberg, E. Theodorsson, B. Angmar-Månsson, Neuropeptides in the saliva of healthy subjects. Life Sci. 60, 269–278 (1997)CrossRefPubMed
51.
C.A. Burdon, P. Ruell, N. Johnson, P. Chapman, S. O’Brien, H.T. O’Connor, The effect of ice-slushy consumption on plasma vasoactive intestinal peptide during prolonged exercise in the heat. J. Therm. Biol. 47, 59–62 (2015)CrossRefPubMed
52.
D. Vaudry, A. Falluel-morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B.K.C. Chow, H. Hashimoto, L. Galas, H. Vaudry, Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 61, 283–357 (2009)CrossRefPubMed
53.
A. Sarrieau, M. Najimi, F. Chigr, N. Kopp, D. Jordan, W. Rostene, Localization and developmental pattern of vasoactive intestinal polypeptide binding sites in the human hypothalamus. Sinapse 17, 129–140 (1994)CrossRef
54.
Y. Masuo, T. Ohtaki, Y. Masuda, M. Tsuda, M. Fujino, Binding sites for pituitary adenyloate cyclase activating polypeptide (PACAP) commparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Brain Res. 575, 113–123 (1992)CrossRefPubMed
55.
L. Mounien, P. Bizet, I. Boutelet, G. Gourcerol, A. Fournier, H. Vaudry, S. Jégou, Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience 143, 155–163 (2006)CrossRefPubMed
56.
L. Mounien, P. Bizet, I. Boutelet, G. Gourcerol, M. Basille, B. Gonzalez, H. Vaudry, S. Jégou, Expression of PACAP receptor mRNAs by neuropeptide Y neurons in the rat arcuate nucleus. Ann. N. Y. Acad. Sci. 1070, 457–461 (2006)CrossRefPubMed
57.
P. Wiik, Glucocorticoids upregulate the high affinity receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes in vitro. Regul. Pept. 35, 19–30 (1991)CrossRefPubMed
Metadaten
Titel
Adrenalectomy impairs vasoactive intestinal peptide-induced changes in food intake and plasma parameters
verfasst von
Marcela Cristina Garnica-Siqueira
Andressa Bussetti Martins
Larissa Rugila dos Stopa
Camila Franciele de Souza
Dimas Augusto Morozin Zaia
Cristiane Mota Leite
Cássia Thaïs Bussamra Vieira Zaia
Ernane Torres Uchôa
Publikationsdatum
19.07.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02012-w

Weitere Artikel der Ausgabe 3/2019

Endocrine 3/2019 Zur Ausgabe

Original Article

Evaluation of cardiovascular risk by growth-differentiation factor-15 and tissue Doppler imaging in children with subclinical hypothyroidism

Letter to the Editor

Letter to “Successful radiofrequency ablation strategies for benign thyroid nodules”

Review

Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome

Research Letter

Human heart shifts from IGF-1 production to utilization with chronic heart failure

Original Article

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways

Clinical Management of Endocrine Diseases

Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise